| Literature DB >> 30197441 |
Travis Laver1, Brittany R Feldhaeusser1, Cecilia S Robat1, Jennifer L Baez1, Kim L Cronin1, Paolo Buracco1, Maurizio Annoni1, Rebecca C Regan1, Sarah K McMillan1, Kaitlin M Curran1, Laura E Selmic1, Kai-Biu Shiu1, Kyle Clark1, Erin Fagan1, Douglas H Thamm1.
Abstract
The medical records of 87 dogs treated with surgery for cutaneous malignant melanoma (CMM) of the haired skin were retrospectively reviewed for overall survival time (OST), progression-free survival time (PFS), and prognostic factors. The post-surgery median PFS and median OST were 1282 days and 1363 days, respectively. The post-surgery metastatic rate was 21.8% with a local recurrence rate of 8%. Increasing mitotic index (MI) was predictive of a significantly decreased OST and PFS on multivariable analysis [hazard ratio (HR): 1.05, 95% confidence interval (CI): 1.02 to 1.07 and HR: 1.04, 95% CI: 1.02 to 1.06, respectively]. Increasing age was likewise predictive of a significantly decreased OST and PFS on multivariable analysis (HR: 1.39, 95% CI: 1.17 to 1.65 and HR: 1.33, 95% CI: 1.14 to 1.54, respectively). These results confirm clinical impressions that long survival times are likely in dogs diagnosed with malignant melanoma of the haired skin when treated with surgery alone.Entities:
Mesh:
Year: 2018 PMID: 30197441 PMCID: PMC6091115
Source DB: PubMed Journal: Can Vet J ISSN: 0008-5286 Impact factor: 1.008